指南与共识支持与姑息治疗胸部肿瘤

晚期癌症呼吸困难管理:ASCO指南

Management of Dyspnea in Advanced Cancer: ASCO Guideline.
指南 / 共识 · J Clin Oncol · 2021-02-22

ASCO专家组基于AHRQ系统评价(48项RCT和2项回顾性队列研究)及其他系统评价制定晚期成人癌症呼吸困难管理指南。推荐采用阶梯式管理:先评估呼吸困难、查明并处理可逆病因、转诊跨学科姑息治疗团队;非药物干预(如风扇、氧疗)可缓解症状,效果不足时使用全身性阿片类药物。

要点

  • 阶梯式管理:评估→处理可逆病因→转诊姑息团队→非药物干预→阿片类药物
  • 非药物干预包括气流干预(风扇吹面颊)、低氧血症者标准补氧及心理教育等
  • 非药物干预缓解不足时,应提供全身性阿片类药物

核心结论

  • 推荐对晚期癌症成人患者的呼吸困难采用阶梯式管理方法。

研究设计与样本

  • ASCO召集专家组,基于AHRQ系统评价(纳入48项RCT和2项回顾性队列研究,截至2020年5月初发表)及其他系统评价(截至2020年7月)制定指南。

主要发现

  • 肺癌和间皮瘤是最常涉及的癌症类型。
  • 风扇等非药物干预对呼吸困难有一定缓解作用。
  • 药物干预的支持证据有限。
  • 专科呼吸困难服务的荟萃分析显示呼吸困难所致痛苦有所改善。

关键数值与推荐

  • 推荐首先评估呼吸困难、查明并管理潜在可逆病因,并转诊跨学科姑息治疗团队。
  • 可提供的非药物干预包括气流干预(如风扇吹向面颊)、低氧血症患者的标准补充氧疗及其他心理教育、自我管理或补充方法。
  • 对非药物干预缓解不足的患者,应提供全身性阿片类药物。
  • 其他药物干预如皮质类固醇和苯二氮䓬类药物也有讨论。

临床怎么用

  • 临床应按阶梯流程管理晚期癌症呼吸困难,优先评估和处理可逆病因并转诊姑息团队。
  • 可先尝试风扇等非药物干预,低氧血症者给予标准补氧。
  • 非药物干预效果不佳时,及时使用全身性阿片类药物。

局限性

  • 药物干预的支持证据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide guidance on the clinical management of dyspnea in adult patients with advanced cancer. METHODS: ASCO convened an Expert Panel to review the evidence and formulate recommendations. An Agency for Healthcare Research and Quality (AHRQ) systematic review provided the evidence base for nonpharmacologic and pharmacologic interventions to alleviate dyspnea. The review included randomized controlled trials (RCTs) and observational studies with a concurrent comparison group published through early May 2020. The ASCO Expert Panel also wished to address dyspnea assessment, management of underlying conditions, and palliative care referrals, and for these questions, an additional systematic review identified RCTs, systematic reviews, and guidelines published through July 2020. RESULTS: The AHRQ systematic review included 48 RCTs and two retrospective cohort studies. Lung cancer and mesothelioma were the most commonly addressed types of cancer. Nonpharmacologic interventions such as fans provided some relief from breathlessness. Support for pharmacologic interventions was limited. A meta-analysis of specialty breathlessness services reported improvements in distress because of dyspnea. RECOMMENDATIONS: A hierarchical approach to dyspnea management is recommended, beginning with dyspnea assessment, ascertainment and management of potentially reversible causes, and referral to an interdisciplinary palliative care team. Nonpharmacologic interventions that may be offered to relieve dyspnea include airflow interventions (eg, a fan directed at the cheek), standard supplemental oxygen for patients with hypoxemia, and other psychoeducational, self-management, or complementary approaches. For patients who derive inadequate relief from nonpharmacologic interventions, systemic opioids should be offered. Other pharmacologic interventions, such as corticosteroids and benzodiazepines, are also discussed.Additional information is available at www.asco.org/supportive-care-guidelines.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Hui D, Bohlke K, Bao T, et al. Management of Dyspnea in Advanced Cancer: ASCO Guideline. J Clin Oncol. 2021. PMID: 33617290. doi:10.1200/JCO.20.03465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。